Expression analyses in PCa patient samples and the DU145 cell line indicated elevated levels of NUTM2A‐AS1 and PRMT5, with a concomitant reduction in miR‐376a‐3p. This evidence concerns the gene PRMT5 and posterior cortical atrophy.